search button
Open Access

Prognostic implications of the BRAF‑V600E mutation in papillary thyroid carcinoma based on a new cut‑off age stratification

  • Authors:
    • Xiaoxiong Gan
    • Fei Shen
    • Xingyan Deng
    • Jianhua Feng
    • Jiabao Lu
    • Wensong Cai
    • Lina Peng
    • Weipeng Zheng
    • Weijia Wang
    • Peidan Huang
    • Zhen Chen
    • Mengli Guo
    • Bo Xu

  • View Affiliations

  • Published online on: November 21, 2019     https://doi.org/10.3892/ol.2019.11132
  • Pages: 631-640

  • Copyright : © Gan et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY 4.0].

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

The BRAF‑V600E mutation is the most common and specific oncogenic event known in papillary thyroid carcinoma (PTC). However, it remains controversial whether there is an association between the BRAF‑V600E mutation and clinicopathologically aggressive characteristics of PTC. The purpose of the present retrospective study was to investigate the significance of the BRAF‑V600E mutation in predicting prognostic and aggressive clinicopathological characteristics according to a new age‑based stratification. Clinical data and the BRAF‑V600E mutation status of 475 patients with PTC were downloaded from The Cancer Genome Atlas database. The association between BRAF‑V600E status and clinicopathological characteristics was analyzed by χ2 test or Fisher's exact test. Recurrence‑free survival rate (RFS) was analyzed using the Kaplan‑Meier method. Aggressive clinicopathological factors associated with recurrence were analyzed by Cox multivariate regression. This study was conducted on 219 cases of patients with PTC with a known BRAF‑V600E mutational status. In the ≥55 years age group, BRAF‑V600E was found to be significantly associated with aggressive PTC characteristics, including tumor size, PTC subtype, radioactive iodine (RAI) dose, follow‑up time, recurrence, recurrence risk stage, advanced T stage, advanced N stage and American Joint Committee on Cancer (III/IV) stage (all P<0.05). RFS was analyzed by the log‑rank test and exhibited statistically significant differences in the ≥55 years group (P=0.041), but there was no significant difference in the <55 group (P=0.757), according to the BRAF‑V600E mutation status. The BRAF‑V600E gene was excluded from the recurrence Cox multivariate regression model. The BRAF‑V600E mutation was found to better predict aggressive and recurrent PTC based on age stratification with the cut‑off age of 55 years. The synergistic interaction between BRAF‑V600E mutation and the new age stratification may help clinicians reach the optimal decision in terms of surgical approach and the extent of surgery.
View Figures
View References

Related Articles

Journal Cover

January-2020
Volume 19 Issue 1

Print ISSN: 1792-1074
Online ISSN:1792-1082

Sign up for eToc alerts

Recommend to Library

  • Journal Metrics
  • Impact Factor: 2.9
  • Ranked Oncology
    (total number of cites)
  • CiteScore: 6.3
  • CiteScore Rank: Q2: #119/366 Oncology
  • Source Normalized Impact per Paper (SNIP): 0.725
  • SCImago Journal Rank (SJR): 0.639
International Symposium on Molecular Medicine Conference Banner
The Cancer Story
World Congress on Advances in Oncology and International Symposium on Molecular Medicine Conference Banner
World Academy Of Sciences Banner
Heyday Road Banner

0

Copy and paste a formatted citation
x
Spandidos Publications style
Gan X, Shen F, Deng X, Feng J, Lu J, Cai W, Peng L, Zheng W, Wang W, Huang P, Huang P, et al: Prognostic implications of the BRAF‑V600E mutation in papillary thyroid carcinoma based on a new cut‑off age stratification. Oncol Lett 19: 631-640, 2020
APA
Gan, X., Shen, F., Deng, X., Feng, J., Lu, J., Cai, W. ... Xu, B. (2020). Prognostic implications of the BRAF‑V600E mutation in papillary thyroid carcinoma based on a new cut‑off age stratification. Oncology Letters, 19, 631-640. https://doi.org/10.3892/ol.2019.11132
MLA
Gan, X., Shen, F., Deng, X., Feng, J., Lu, J., Cai, W., Peng, L., Zheng, W., Wang, W., Huang, P., Chen, Z., Guo, M., Xu, B."Prognostic implications of the BRAF‑V600E mutation in papillary thyroid carcinoma based on a new cut‑off age stratification". Oncology Letters 19.1 (2020): 631-640.
Chicago
Gan, X., Shen, F., Deng, X., Feng, J., Lu, J., Cai, W., Peng, L., Zheng, W., Wang, W., Huang, P., Chen, Z., Guo, M., Xu, B."Prognostic implications of the BRAF‑V600E mutation in papillary thyroid carcinoma based on a new cut‑off age stratification". Oncology Letters 19, no. 1 (2020): 631-640. https://doi.org/10.3892/ol.2019.11132